Replies to post #749 on Heron Therapeutics Inc. (HRTX)

[kookiekook]

The official policy of the SEC on trading halts is as follows:

There are two types of trading halts and delays—regulatory and nonregulatory. The most common regulatory halt and delay happen when a company has pending news that may affect the security’s price (a "news pending" halt or delay). By halting or delaying trading, market participants can have time to assess the impact of the news. Another type of regulatory halt happens when a market halts trading in a security when there is uncertainty over whether the security continues to meet the market’s listing standards. When a regulatory halt or delay is imposed by a security’s primary market, the other U.S. markets that also trade the security honor this halt.

Since we have no information on APPA having listing problems, and we anticipated an FDA notification, we can assume that the FDA has or is releasing its decision.